Trial Outcomes & Findings for Identifying the Anti-Blood-Clotting Compounds in Garlic (NCT NCT00200785)
NCT ID: NCT00200785
Last Updated: 2010-01-11
Results Overview
percent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)
COMPLETED
NA
9 participants
4 weeks
2010-01-11
Participant Flow
healthy participants were recruited in Utah county, Utah, in early 2006
Participant milestones
| Measure |
Garlic Powder: High Allicin
garlic powder in ambient water
|
Garlic Powder: No Allicin
garlic powder in boiling water
|
|---|---|---|
|
First Intervention
STARTED
|
9
|
6
|
|
First Intervention
COMPLETED
|
9
|
6
|
|
First Intervention
NOT COMPLETED
|
0
|
0
|
|
Washout Period of 1 Week
STARTED
|
9
|
6
|
|
Washout Period of 1 Week
COMPLETED
|
9
|
6
|
|
Washout Period of 1 Week
NOT COMPLETED
|
0
|
0
|
|
Second Intervention
STARTED
|
9
|
6
|
|
Second Intervention
COMPLETED
|
9
|
6
|
|
Second Intervention
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Identifying the Anti-Blood-Clotting Compounds in Garlic
Baseline characteristics by cohort
| Measure |
Garlic Powder: High Allicin
n=9 Participants
garlic powder in ambient water
|
Garlic Powder: No Allicin
n=6 Participants
garlic powder in boiling water
|
Total
n=15 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0.0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
15.0 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0.0 Participants
n=206 Participants
|
|
Age Continuous
|
32.2 years
STANDARD_DEVIATION 13.7 • n=99 Participants
|
36.5 years
STANDARD_DEVIATION 15.1 • n=107 Participants
|
32.2 years
STANDARD_DEVIATION 13.7 • n=206 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
7.0 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
8.0 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
9 participants
n=99 Participants
|
6 participants
n=107 Participants
|
15.0 participants
n=206 Participants
|
|
electrical impedance (ohms) at 0 weeks
|
12.7 ohms
STANDARD_DEVIATION 1.2 • n=99 Participants
|
15.0 ohms
STANDARD_DEVIATION 1.6 • n=107 Participants
|
13.9 ohms
STANDARD_DEVIATION 1.4 • n=206 Participants
|
|
percent platelet aggregation at 0 weeks
|
76.0 percent platelet aggregation
STANDARD_DEVIATION 1.6 • n=99 Participants
|
71.8 percent platelet aggregation
STANDARD_DEVIATION 5.7 • n=107 Participants
|
73.9 percent platelet aggregation
STANDARD_DEVIATION 3.7 • n=206 Participants
|
PRIMARY outcome
Timeframe: 4 weekspercent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)
Outcome measures
| Measure |
Garlic Powder: High Allicin
n=9 Participants
garlic powder in ambient water
|
Garlic Powder: No Allicin
n=6 Participants
garlic powder in boiling water
|
|---|---|---|
|
Percent Platelet Aggregation
|
71.4 percent platelet aggregation
Standard Deviation 4.3
|
72.5 percent platelet aggregation
Standard Deviation 5.5
|
SECONDARY outcome
Timeframe: 4 weeksPopulation: Nine persons participated in the "high allicin" test. Six of the same persons participated in the "no allicin" test.
Electrical impedance (ohms) was measured using 0.5 mL of whole blood plus 0.5 mL saline in a Chronolog Whole Blood aggregometer. Ten mL of whole blood were collected and tested every week. There is no mathematical correlation between impedance (ohms) and percent aggregation.
Outcome measures
| Measure |
Garlic Powder: High Allicin
n=9 Participants
garlic powder in ambient water
|
Garlic Powder: No Allicin
n=6 Participants
garlic powder in boiling water
|
|---|---|---|
|
Electrical Impedance in Ohms
|
13.8 ohms
Standard Deviation 1.5
|
15.0 ohms
Standard Deviation 1.5
|
Adverse Events
Garlic Powder: High Allicin
Garlic Powder: No Allicin
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Larry D. Lawson
Silliker, Inc./Plant Bioactives Research Institute, Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place